Chief Executive Officer
Bruce Cohen has officially joined Prime Biologics in April 2017.
Bruce brings with him a wealth of business leadership experience in the areas of pharmaceuticals and medical technology, with strong business networks in the United States, where he has spent well over 30 years of Management, Marketing and Business Development experience in life sciences and high technology companies.
He was the founding President and CEO of three early stage biotechnology companies; served as CFO for GeneSoft Pharmaceuticals Inc. prior to its merger with Oscient Pharmaceuticals; held senior positions in business development and marketing at SEQUUS Pharmaceuticals Inc. and in the International, Management Services and Information Technology business units at Baxter International.
Bruce was the President and COO of ViTel International Inc., a privately held, pre-internet electronic messaging company. He also served as a management consultant with Monitor Company, working in the healthcare and high technology sectors. Bruce was a member of the founding team of the Tufts Veterinary School and a Regional Manager of the National Health Professions Placement Network.
More recently, Bruce served as Executive Chairman of Xagenic Inc. from 2012 to 2014. He currently serves as a Board member and Chairman of ViroPro, a public company, and CEO of, MEC Dynamics Corporation, a privately held company, and was instrumental in orchestrating the on-going turnaround of both these companies.
Bruce holds a BA, cum laude (1975) and an MA (1980) from Tufts University; and an MBA, with distinction (1982) from Harvard Business School, Harvard University.